- The Trade Hub
- ...News
- Regulation
- The Commission opens its first IPI revie...
The Commission opens its first IPI review until 27 November 2026.
The European Commission has opened a public consultation, running from 4 September to 27 November 2026, on the first review of Regulation (EU) 2022/1031 establishing the IPI.
Consultation open until 27 November 2026
The European Commission's Directorate-General for Trade and Economic Security published, on 10 September 2026, a notice opening a public consultation on the first review of the International Procurement Instrument, or IPI . The consultation will remain open for 12 weeks, from 4 September to 27 November 2026 .
According to the Commission, the review is conducted under Article 14 of Regulation (EU) 2022/1031 of the European Parliament and of the Council of 23 June 2022 on the access of third-country economic operators, goods and services to the Union’s public procurement and concession markets and procedures supporting negotiations on access of Union economic operators, goods and services to the public procurement and concession markets of third countries . The Regulation was published in the Official Journal of the European Union, OJ L 173 of 30 June 2022 .
Article 14 provides for the Commission to review the scope, operation and effectiveness of the Regulation . The Commission will submit the conclusions of that review to the European Parliament and the Council .
The notice states that the consultation seeks evidence and comments from Union producers, contracting authorities, traders, importers and other interested parties . The consultation topics include the scope, rules for determining origin, investigations, thresholds, measures and their exceptions .
Scope, origin, thresholds and measures under review
The consultation gathers comments on the scope, operation and effectiveness of the IPI . It covers in particular the instrument’s scope and the rules for determining origin .
The Commission includes the effectiveness of the online tool for submitting complaints concerning barriers encountered in third-country public procurement markets . The review also covers investigations conducted under the IPI and consultations with non-EU countries .
The consultation topics include the effectiveness of the thresholds for applying measures, as well as the form and scope of those measures . The Commission also cites the implementation of obligations applicable to successful tenderers and exceptions to IPI measures .
According to the EUR-Lex summary, IPI measures may target undertakings, goods or services from non-EU countries that are party neither to the World Trade Organization’s plurilateral Agreement on Government Procurement nor to a bilateral or multilateral trade agreement concluded with the Union containing public procurement or concession market-access commitments . They may also apply to undertakings, goods or services from countries party to such agreements, but only in procurement procedures concerning goods, services or concessions not covered by those agreements .
The precedent of Chinese medical devices
The European Commission initiated an own-initiative investigation on 24 April 2024, under Article 5(1) of Regulation (EU) 2022/1031 . The investigation concerned alleged measures and practices by the People’s Republic of China in its public procurement market for medical devices, which the Commission said severely and repeatedly restricted access for Union undertakings and medical devices .
According to the Commission, the experience gained from that first investigation and the first IPI measure on medical devices is among the elements considered in the review . According to the Directorate-General for Trade and Economic Security publication, this experience covers the application of the Regulation and the measure by contracting authorities, contracting entities and undertakings .
After publishing its investigation report and failing to reach an acceptable solution with China, the Commission adopted the first IPI measure on 19 June 2025 . Commission Implementing Regulation (EU) 2025/1197, also dated 19 June 2025, establishes that measure and restricts access to Union public procurement markets for economic operators and medical devices originating in the People’s Republic of China . The Commission describes those restrictions as targeted .
On 30 July 2025, the Commission published a report on the application of the IPI Regulation, setting out the tools for its implementation, the investigation into Chinese medical devices and lessons drawn from applying the instrument . The available file provides neither the consultation questionnaire nor a link to its response form .
Sources cited
- policy.trade.ec.europa.eu - La Commission européenne ouvre la consultation sur le premier réexamen de l'instrument relatif aux marchés publics internationaux
- eur-lex.europa.eu - L’instrument européen relatif aux marchés publics internationaux — IMPI | EUR-Lex
- marches.public.lu - Portail des marchés publics - Luxembourg